$16.10
0.16% today
NYSE, Apr 03, 06:46 pm CET
ISIN
US7050151056
Symbol
PSO

Pearson PLC Sponsored ADR Stock price

$16.07
-1.14 6.62% 1M
+2.56 18.95% 6M
-0.05 0.31% YTD
+3.21 24.96% 1Y
+6.05 60.38% 3Y
+9.48 143.85% 5Y
-5.29 24.77% 10Y
NYSE, Closing price Wed, Apr 02 2025
-0.03 0.19%
ISIN
US7050151056
Symbol
PSO
Industry

Key metrics

Market capitalization $10.92b
Enterprise Value $12.10b
P/E (TTM) P/E ratio 19.34
EV/FCF (TTM) EV/FCF 10.41
EV/Sales (TTM) EV/Sales 2.67
P/S ratio (TTM) P/S ratio 2.40
P/B ratio (TTM) P/B ratio 2.11
Dividend yield 1.91%
Last dividend (FY24) $0.31
Revenue growth (TTM) Revenue growth -0.59%
Revenue (TTM) Revenue $4.54b
EBIT (operating result TTM) EBIT $698.92m
Free Cash Flow (TTM) Free Cash Flow $1.16b
EPS (TTM) EPS $0.83
P/E forward 18.94
P/S forward 2.29
EV/Sales forward 2.54
Short interest 0.12%
Show more

Is Pearson PLC Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Pearson PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Pearson PLC Sponsored ADR forecast:

3x Buy
30%
7x Hold
70%

Analyst Opinions

10 Analysts have issued a Pearson PLC Sponsored ADR forecast:

Buy
30%
Hold
70%

Financial data from Pearson PLC Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
4,539 4,539
1% 1%
100%
- Direct Costs 2,225 2,225
3% 3%
49%
2,315 2,315
1% 1%
51%
- Selling and Administrative Expenses 961 961
1% 1%
21%
- Research and Development Expense - -
-
-
1,354 1,354
3% 3%
30%
- Depreciation and Amortization 655 655
3% 3%
14%
EBIT (Operating Income) EBIT 699 699
10% 10%
15%
Net Profit 556 556
18% 18%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Pearson PLC Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pearson PLC Sponsored ADR Stock News

Neutral
GlobeNewsWire
about 6 hours ago
MNV-201 is Minovia's second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria Rare Pediatr i c Designation granted MNV-201 is also being studied in a Phase Ib for low-risk Myelodysplastic Syndrome; Preliminary clinical data demonstrate safety and efficacy HAIFA, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- Minovia T...
Neutral
Business Wire
2 days ago
WOODBRIDGE, N.J.--(BUSINESS WIRE)-- #HR--ExtensisHR's David R. Pearson has been named “CHRO of the Year (PEO & HRO) – New Jersey 2025” by C-Suite Insider.
Neutral
PRNewsWire
3 days ago
Dave Treat to lead Pearson's digital and technology operation, expanding his current architectural and innovation responsibilities LONDON , March 31, 2025 /PRNewswire/ -- Pearson (FTSE: PSON.L), the world's lifelong learning company, announced today that Dave Treat, Pearson's Chief Technology Officer, will assume leadership of the company's digital and technology operation alongside his current...
More Pearson PLC Sponsored ADR News

Company Profile

Pearson Plc is an education company, which engages in the business of education, business information, and consumer publishing markets. It operates through the following segments: North America, Core, and Growth. The North America segment includes businesses in the Unites States and Canada. The Core segment referst to businesses in mature markets including the United Kingdom, Australia, and Italy. The Growth segment covers the businesses in emerging markets including Brazil, China, India, and South Africa. The company was founded by Pearson Samuel in 1844 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Omar Abbosh
Employees 17,116
Founded 1844
Website plc.pearson.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today